Publikationsserver der Universitätsbibliothek Marburg
Titel:A key role for BID-mediated mitochondrial damage in oxidative cell death
Autor:Jelinek, Anja Maria
Weitere Beteiligte: Culmsee, Carsten (Prof. Dr.)
Veröffentlicht:2018
URI:https://archiv.ub.uni-marburg.de/diss/z2018/0088
URN: urn:nbn:de:hebis:04-z2018-00880
DOI: https://doi.org/10.17192/z2018.0088
DDC:615 Pharmakologie, Therapeutik
Titel (trans.):Eine Schlüsserolle von BID-vermittelten Mitochondrienschäden im oxidativen Zelltod
Publikationsdatum:2018-02-28
Lizenz:https://rightsstatements.org/vocab/InC-NC/1.0/

Dokument

Schlagwörter:
ferroptosis, BID, mitochondria, oxytosis, Ferroptose, Nervenzelle, Mitochondrien, Neuronaler Zelltod, neuronal cell death, HT22, HT22, Zelltod, Oxytose, BID

Summary:
Age-related neuropathologies, such as Alzheimer’s and Parkinson’s disease as well as acute brain injury commonly involve oxidative stress-induced disruption of the intracellular calcium homeostasis, disturbed redox balance and impaired energy metabolism attributed to mitochondrial damage which eventually drives neuronal cells to death. Thus, identifying biochemical features underlying the detrimental impairment of mitochondrial integrity and function is key to develop therapeutic strategies preventing neuronal loss. To date, a great variety of regulated cell death modalities has been established in neuronal death. In particular, apoptosis, excitotoxicity and regulated necrosis were shown to play a prominent role, and tight crosstalk between these paradigms of cell death exists, especially via convergence at the mitochondria. Despite increasing knowledge on cell death pathways, for many neurodegenerative diseases no curative treatment is available, so far. Over the last decades, a number of publications proposed the involvement of BCL-2-family proteins like BID and BAX in mediating mitochondrial cell death. For the protein BID, the contribution to neuronal apoptosis during ischemia has been widely established in vivo, exposing BID inhibition as a promising future therapy option. However, in non-apoptotic models of oxidative cell death, for instance ferroptosis, the role of BID and involvement of mitochondrial damage in cell death execution remained to be elucidated. In addition, the exact mechanisms how lipid ROS formation triggers BID activation and mitochondrial demise are still unknown. Due to high energy utilization for the maintenance of the membrane potential, neurotransmitter synthesis and restoring intracellular ion pools after action potentials, neurons strongly rely on oxygen and functional energy metabolism, thus being vulnerable to loss of mitochondrial function. The aim of this study was to determine hallmarks of regulated oxidative cell death pathways with respect to their time-dependent progression, involvement of BID as well as mitochondrial damage. Therefore, CRISPR/Cas9 technology was applied to generate neuronal HT22 cell lines lacking BID in order to analyze their sensitivity to oxidative stress induced by erastin and RSL3. Further, protective effects of MitoQ were investigated to evaluate the therapeutic potential of this mitochondria-targeted ROS scavenger in models of ferroptosis. Additionally, this work aimed to improve BID crystallization with novel recombinant protein constructs and optimized crystallization conditions. The first part of the thesis reports on the involvement of mitochondrial damage in oxidative death signaling in neuronal HT22 cells and mouse embryonic fibroblasts. In the model of glutamate-induced oxytosis, which is concentration- and cell density-dependent, impairment of mitochondrial respiration occurred in a time-dependent manner. In this cell death paradigm mitochondrial damage was represented the point of no return in the cell’s commitment to die as the well-established BID inhibitor BI-6c9 could rescue the cells within a time window of up to 8 hours after onset of glutamate exposure when massive mitochondrial damage was observed. The comprehensive analysis of erastin-induced oxidative death revealed a close interconnection of the previously separated cell death pathways of oxytosis and ferroptosis. In a time-dependent manner, erastin induced loss of mitochondrial membrane potential and lipid peroxidation followed by cell death 8 to 10 hours after treatment onset. Mitochondrial ROS production and loss of mitochondrial function was observed after 6 hours, and was tightly connected to severe mitochondrial fission thereby underlining the major finding of mitochondrial damage as the converging point of death signaling in neural and MEF cells in this paradigm of erastin-induced ferroptosis. In addition, siRNA-mediated AIF knockdown mitigated cell death in HT22 cells exposed to erastin, revealing a significant role for AIF release from mitochondria in ferroptosis similar to earlier findings in glutamate-induced oxytosis. The second part of the thesis focused on the involvement of BID in mitochondrial cell death pathways. SiRNA approach and CRISPR/Cas9 Bid knockout in HT22 cells revealed a significant contribution of BID in mediating mitochondrial demise upon oxidative stress. BID deprived cells were not only protected against glutamate- or erastin-induced cell death but also their mitochondrial parameters, such as membrane potential, ROS production and morphology were preserved at control levels. In contrast, tBID overexpression in Bid KO cells reversed the protective effects of BID absence and led to a significant increase in lipid ROS formation and cell death. In addition to shared BID involvement, mechanistic overlap of oxytosis and ferroptosis could be shown by the comparable cell protection against glutamate and erastin challenge by the ferroptosis inhibitor liproxstatin. Direct GPX4 inhibition by 1S, 3R-RSL3 and protection mediated by the mitochondria-targeted antioxidant MitoQ further established significant contribution of ROS formation to mitochondrial damage and again highlighted a role for BID as Bid KO cells were less sensitive to RSL3-mediated ferroptosis. Overall, these findings highlight a key role for BID in both paradigms of oxytosis and ferroptosis and expose BID transactivation to the mitochondria, mitochondrial oxidative damage and AIF-release as common mechanistic hallmarks linking these pathways. Finally, the 3D structure of BID should be elucidated by X-ray crystallography and, therefore, novel recombinant Bid constructs were established. For the first time, BID crystals could be obtained in a reproducible manner and were optimized by improving protein constructs and crystallization conditions. In order to solve the phase problem, selenomethionine crystals were grown, however, the resolution of electron density data was not sufficient to solve the molecular 3D structure of BID but provide a promising basis for further optimization.

Bibliographie / References

  1. Jelinek, A.; Heyder, L.; Daude, M.; Plessner, M.; Krippner, S.; Grosse, R.; Diederich, W. E..; Culmsee, C.; A BID of ferroptosis, 25 th Euroconference on Apoptosis (ECDO): Cell death and immunity in disease; from molecules to translational medicine, Leuven, Belgium (2017)
  2. Skulachev, V.P. (2007) A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Moscow) 72, 1385-1396
  3. Doll, S. et al. (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature chemical biology 13, 91- 98
  4. Scorrano, L. et al. (2002) A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during Apoptosis. Developmental cell 2, 55-67
  5. Snow, B.J. et al. (2010) A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 25, 1670-1674
  6. Kim, H. and Kim, J.-S. (2014) A guide to genome engineering with programmable nucleases. Nature reviews. Genetics 15, 321- 334
  7. Oxler, E.-M. et al. (2012) AIF depletion provides neuroprotection through a preconditioning effect. Apoptosis : an international journal on programmed cell death 17, 1027-1038
  8. Baritaud, M. et al. (2012) AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation. Cell death & disease 3, e390
  9. Artus, C. et al. (2010) AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. The EMBO journal 29, 1585-1599
  10. Deas, E. et al. (2016) Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease. Antioxidants & redox signaling 24, 376-391
  11. Cong, W.-n. et al. (2012) Altered hypothalamic protein expression in a rat model of Huntington's disease. PloS one 7, e47240
  12. Smith, R.A.J. and Murphy, M.P. (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences 1201, 96-103
  13. Li, Z. et al. (2017) Anti-Oxidative Stress Activity Is Essential for Amanita caesarea Mediated Neuroprotection on Glutamate- Induced Apoptotic HT22 Cells and an Alzheimer's Disease Mouse Model. International journal of molecular sciences 18
  14. Wang, Y. et al. (2016) A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science (New York, N.Y.) 354
  15. Kerr, J.F. et al. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British journal of cancer 26, 239-257
  16. Elmore, S. (2007) Apoptosis: a review of programmed cell death. Toxicologic pathology 35, 495-516
  17. Cheung, E.C.C. et al. (2005) Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. The Journal of neuroscience : the official journal of the Society for Neuroscience 25, 1324-1334
  18. Sevrioukova, I.F. (2011) Apoptosis-inducing factor: structure, function, and redox regulation. Antioxidants & redox signaling 14, 2545-2579
  19. Culmsee, C. et al. (2005) Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. The Journal of neuroscience : the official journal of the Society for Neuroscience 25, 10262-10272
  20. Schulze-Osthoff, K. et al. (1998) Apoptosis signaling by death receptors. European journal of biochemistry 254, 439-459
  21. Tompkins, M.M. et al. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. The American journal of pathology 150, 119-131
  22. Jinek, M. et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (New York, N.Y.) 337, 816-821
  23. McGarry, A. et al. (2017) A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88, 152-159
  24. Li, Y. et al. (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463
  25. Gonzalez, Y. et al. (2014) Atg7-and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 5, 1526-1537
  26. van Leyen, K. et al. (2006) Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37, 3014-3018
  27. Peña-Blanco, A. and García-Sáez, A.J. (2017) Bax, Bak and beyond: mitochondrial performance in apoptosis. The FEBS journal 139. Perry, V.H. et al. (2010) Microglia in neurodegenerative disease. Nature reviews. Neurology 6, 193-201
  28. Basañez, G. et al. (1999) Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proceedings of the National Academy of Sciences of the United States of America 96, 5492-5497
  29. Czabotar, P.E. et al. (2013) Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 152, 519-531
  30. Saito, M. et al. (2000) BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nature cell biology 2, 553-555
  31. Gahl, R.F. et al. (2016) Bcl-2 proteins bid and bax form a network to permeabilize the mitochondria at the onset of apoptosis. Cell death & disease 7, e2424
  32. Kuwana, T. et al. (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Molecular cell 17, 525-535
  33. Rajan, S. et al. (2015) Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Proteins 83, 1262-1272
  34. Billen, L.P. et al. (2008) Bid: a Bax-like BH3 protein. Oncogene 27 Suppl 1, S93-104
  35. Luo, X. et al. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490
  36. Wang, K. et al. (1996) BID: a novel BH3 domain-only death agonist. Genes & development 10, 2859-2869
  37. Wei, Q. et al. (2006) Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice. American journal of physiology. Renal physiology 290, F35-42
  38. Yin, X.M. et al. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891
  39. Ding, W.-X. et al. (2004) Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology (Baltimore, Md.) 40, 403-413
  40. Garcia-Perez, C. et al. (2012) Bid-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proceedings of the National Academy of Sciences of the United States of America 109, 4497-4502
  41. Landshamer, S. et al. (2008) Bid-induced release of AIF from mitochondria causes immediate neuronal cell death. Cell death and differentiation 15, 1553-1563
  42. Neitemeier, S. et al. (2017) BID links ferroptosis to mitochondrial cell death pathways. Redox biology 12, 558-570
  43. Dolga, A.M., Oppermann, S., Culmsee, C., Bid links ferroptosis to mitochondrial cell death pathways in neurons. (Redox Biology, 2017)
  44. Jelinek, A.; Neitemeier, S.; Oppermann, S.; Laino, V.; Ganjam, G.K.; Dolga, A.; Culmsee, C., Bid links Ferroptosis to Mitochondrial Demise in Neuronal Cell Death Pathways, EMBO workshop: Mitochondria, Apoptosis and cancer (MAC), Frankfurt, Germany (2015)
  45. Tobaben, S. et al. (2011) Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell death and differentiation 18, 282-292
  46. Yin, X.-M. et al. (2002) Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia. The Journal of biological chemistry 277, 42074-42081
  47. Grohm, J. et al. (2010) Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death. Brain, behavior, and immunity 24, 831-838
  48. Plesnila, N. et al. (2001) BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America 98, 15318-15323
  49. Martin, N.A. et al. (2016) BID Mediates Oxygen-Glucose Deprivation-Induced Neuronal Injury in Organotypic Hippocampal Slice Cultures and Modulates Tissue Inflammation in a Transient Focal Cerebral Ischemia Model without Changing Lesion Volume. Frontiers in cellular neuroscience 10, 14
  50. Köhler, B. et al. (2008) Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects. PloS one 3, e2844
  51. Cabon, L. et al. (2012) BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell death and differentiation 19, 245-256
  52. Sax, J.K. et al. (2002) BID regulation by p53 contributes to chemosensitivity. Nature cell biology 4, 842-849
  53. Olney, J.W. (1969) Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate. Science 164, 719-721
  54. Görlach, A. et al. (2015) Calcium and ROS: A mutual interplay. Redox biology 6, 260-271
  55. Lim, D. et al. (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. The Journal of biological chemistry 283, 5780-5789
  56. Sheehan, J.P. et al. (1997) Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 17, 4612-4622
  57. Gill, S.C. and Hippel, P.H. von (1989) Calculation of protein extinction coefficients from amino acid sequence data. Analytical biochemistry 182, 319-326
  58. Raemy, E. et al. (2016) Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis. Cell death and differentiation 23, 1165-1174
  59. Lutter, M. et al. (2000) Cardiolipin provides specificity for targeting of tBid to mitochondria. Nature cell biology 2, 754-761
  60. Gasiunas, G. et al. (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences of the United States of America 109, E2579-86
  61. Pan, G. et al. (1998) Caspase-9, Bcl-X L , and Apaf-1 Form a Ternary Complex. J. Biol. Chem. 273, 5841-5845
  62. Gross, A. et al. (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. The Journal of biological chemistry 274, 1156-1163
  63. Stefanis, L. (2005) Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 11, 50-62
  64. Tait, S.W.G. and Green, D.R. (2008) Caspase-independent cell death: leaving the set without the final cut. Oncogene 27, 6452- 6461
  65. Stemmer, M. et al. (2015) CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool. PloS one 10, e0124633
  66. Newmeyer, D.D. et al. (1994) Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353-364
  67. Shimada, K. et al. (2016) Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cell chemical biology 23, 225-235
  68. Mattson, M.P. et al. (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Annals of the New York Academy of Sciences 893, 154-175
  69. Roginsky, V.A. et al. (2009) Chain-breaking antioxidant activity of reduced forms of mitochondria-targeted quinones, a novel type of geroprotectors. Aging 1, 481-489
  70. Ruszkiewicz, J. and Albrecht, J. (2015) Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochemistry international 88, 66-72
  71. Yuan, H. et al. (2016) CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochemical and biophysical research communications 478, 838-844
  72. Li, H. et al. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501
  73. Henshall, D.C. et al. (2001) Cleavage of bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiology of disease 8, 568-580
  74. Sato, H. et al. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. The Journal of biological chemistry 274, 11455-11458
  75. Auer, T.O. and Del Bene, F. (2014) CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods (San Diego, Calif.) 69, 142-150
  76. Jelinek, A.; Neitemeier, S.; Hoffmann, L.; Ganjam, G.K.; Culmsee, C.; CRISPR/Cas9 Bid knockout reveals a key role for BID-mediated mitochondrial damage in ferroptosis, Annual DPHG conference, Munich, Germany (2016)
  77. Jelinek, A.; Neitemeier, S.; Hoffmann, L.; Ganjam, G.K.; Culmsee, C.; CRISPR/Cas9 Bid knockout reveals a key role for BID-mediated mitochondrial damage in ferroptosis, PhD student day BPC (2016)
  78. Jelinek, A.; Neitemeier, S.; Hoffmann, L.; Ganjam, G.K.; Culmsee, C.; CRISPR/Cas9 knockout demonstrates a key role for BID as a molecular link in paradigms of oxytosis & ferroptosis, 46 th annual meeting of the Society for neuroscience (SfN), San Diego, USA (2016)
  79. Jelinek, A.; Neitemeier, S.; Oppermann, S.; Laino, V.; Ganjam, G.K.; Dolga, A.; Culmsee, C., CRISPR/Cas9 Knockout reveals a Key Role for Bid-mediated mitochondrial Damage in Paradigms of Oxytosis and Ferroptosis, MARA Day, Marburg, Germany (2015)
  80. Pourcel, C. et al. (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (Reading, England) 151, 653-663
  81. Gilbert, L.A. et al. (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442-451
  82. Paul, B.D. et al. (2014) Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature 509, 96-100
  83. Li, P. et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489
  84. Ashkenazi, A. and Dixit, V.M. (1998) Death receptors: signaling and modulation. Science (New York, N.Y.) 281, 1305-1308
  85. Nitatori, T. et al. (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. The Journal of neuroscience : the official journal of the Society for Neuroscience 15, 1001-1011
  86. Hsu, P.D. et al. (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278
  87. Hu, J. et al. (2014) Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic acids research 42, 4375-4390
  88. Cheung, E.C.C. et al. (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. The EMBO journal 25, 4061-4073
  89. Yuan, J. et al. (2003) Diversity in the mechanisms of neuronal cell death. Neuron 40, 401-413
  90. Hsu, P.D. et al. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nature biotechnology 31, 827-832
  91. Hauser, D.N. et al. (2013) Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free radical biology & medicine 65, 419-427
  92. Paquet, D. et al. (2016) Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533, 125-129
  93. Yamamoto, A. et al. (2006) Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. Journal of neuropathology and experimental neurology 65, 217-225
  94. Gross, A. et al. (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. The EMBO journal 17, 3878-3885
  95. Zhang, Y. et al. (2003) Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death. BMC neuroscience 4, 32
  96. Galluzzi, L. et al. (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell death and differentiation 22, 58-73
  97. Hara, A. et al. (1998) Evidence for apoptosis in human intracranial aneurysms. Neurological research 20, 127-130
  98. Rink, A. et al. (1995) Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. The American journal of pathology 147, 1575-1583
  99. Portera-Cailliau, C. et al. (1997) Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. The Journal of comparative neurology 378, 70-87
  100. Vis, J.C. et al. (2005) Expression pattern of apoptosis-related markers in Huntington's disease. Acta neuropathologica 109, 321- 328
  101. Yu, H. et al. (2017) Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. Journal of cellular and molecular medicine 21, 648-657
  102. Dixon, S.J. et al. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072
  103. Stockwell, B.R. et al. (2017) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171, 273-285
  104. Xie, Y. et al. (2016) Ferroptosis: process and function. Cell death and differentiation 23, 369-379
  105. Skouta, R. et al. (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. Journal of the American Chemical Society 136, 4551-4556
  106. Markesbery, W.R. and Lovell, M.A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiology of aging 19, 33-36
  107. König, H.-G. et al. (2007) Full length Bid is sufficient to induce apoptosis of cultured rat hippocampal neurons. BMC cell biology 8, 7
  108. Chun, E. et al. (2012) Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (London, England : 1993) 20, 967-976
  109. Yang, H. et al. (2014) Generating genetically modified mice using CRISPR/Cas-mediated genome engineering. Nature protocols 9, 1956-1968
  110. Fineran, P.C. and Dy, R.L. (2014) Gene regulation by engineered CRISPR-Cas systems. Current opinion in microbiology 18, 83- 89
  111. Urnov, F.D. et al. (2010) Genome editing with engineered zinc finger nucleases. Nature reviews. Genetics 11, 636-646
  112. Shimada, K. et al. (2016) Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nature chemical biology 12, 497-503
  113. Ankarcrona, M. et al. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973
  114. Murphy, T.H. et al. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558
  115. Dringen, R. and Hirrlinger, J. (2003) Glutathione pathways in the brain. Biological chemistry 384, 505-516
  116. Seiler, A. et al. (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell metabolism 8, 237-248
  117. Schubert, D. et al. (1992) Growth factros and vitamin E modify neuronal glutamate toxicity. Proceedings of the National Academy of Sciences of the United States of America, 8264-8267
  118. Dixon, S.J. et al. (2015) Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS chemical biology 10, 1604-1609
  119. Speer, R.E. et al. (2013) Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. Free radical biology & medicine 62, 26-36
  120. Dolma, S. et al. (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer cell 3, 285-296
  121. Hegde, R. et al. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. The Journal of biological chemistry 277, 432-438
  122. Yoritaka, A. et al. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 93, 2696-2701
  123. Aoyama, K. and Nakaki, T. (2013) Impaired glutathione synthesis in neurodegeneration. International journal of molecular sciences 14, 21021-21044
  124. Diemert, S. et al. (2012) Impedance measurement for real time detection of neuronal cell death. Journal of neuroscience methods 203, 69-77
  125. Friedmann Angeli, J.P. et al. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nature cell biology 16, 1180-1191
  126. Williams, T.I. et al. (2006) Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiology of aging 27, 1094-1099
  127. van Chu, T. et al. (2015) Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nature biotechnology 33, 543-548
  128. Morimoto, B.H. and Koshland, D.E. (1990) Induction and expression of long-and short-term neurosecretory potentiation in a neural cell line. Neuron 5, 875-880
  129. Liu, X. et al. (1996) Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c. Cell 86, 147-157
  130. van Horssen, J. et al. (2017) Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? Neuroscience letters
  131. Doti, N. et al. (2014) Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress. Cell death & disease 5, e993
  132. Mojica, F.J.M. et al. (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. Journal of molecular evolution 60, 174-182
  133. Fanzani, A. and Poli, M. (2017) Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. International journal of molecular sciences 18
  134. Chen, L. et al. (2008) Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. Journal of neurochemistry 107, 197-207
  135. Ross, M.F. et al. (2005) Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Moscow) 70, 222-230
  136. Shintoku, R. et al. (2017) Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer science
  137. Dagda, R.K. et al. (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. The Journal of biological chemistry 284, 13843-13855
  138. Fukui, M. et al. (2009) Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. European journal of pharmacology 617, 1-11
  139. Savitskaya, M.A. and Onishchenko, G.E. (2015) Mechanisms of Apoptosis. Biochemistry. Biokhimiia 80, 1393-1405
  140. Albrecht, P. et al. (2010) Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc-as a neuroprotective drug target. CNS & neurological disorders drug targets 9, 373-382
  141. Cheung, N.S. et al. (1998) Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult- dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology 37, 1419-1429
  142. van Dommelen, S.M. et al. (2012) Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. Journal of controlled release : official journal of the Controlled Release Society 161, 635-644
  143. Martinou, J.-C. and Youle, R.J. (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Developmental cell 21, 92-101
  144. Starkov, A.A. et al. (2004) Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell calcium 36, 257-264
  145. Grinberg, M. et al. (2005) Mitochondrial carrier homolog 2 is a target of tBID in cells signaled to die by tumor necrosis factor alpha. Molecular and cellular biology 25, 4579-4590
  146. Zamzami, N. et al. (1996) Mitochondrial control of nuclear apoptosis. The Journal of experimental medicine 183, 1533-1544
  147. Lin, M.T. and Beal, M.F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787- 795
  148. Marí, M. et al. (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxidants & redox signaling 11, 2685-2700
  149. Galluzzi, L. et al. (2009) Mitochondrial membrane permeabilization in neuronal injury. Nature reviews. Neuroscience 10, 481- 494
  150. Doughan, A.K. and Dikalov, S.I. (2007) Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxidants & redox signaling 9, 1825-1836
  151. Arnoult, D. et al. (2002) Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. The Journal of cell biology 159, 923-929
  152. Culmsee, C.; Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. (submitted to Free Radical Biology & Medicine, 2017)
  153. Fink, B.D. et al. (2009) Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PloS one 4, e4250
  154. Cheng, G. et al. (2012) Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer research 72, 2634-2644
  155. Wang, Y. and Qin, Z.-H. (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis : an international journal on programmed cell death 15, 1382-1402
  156. Katz, C. et al. (2012) Molecular basis of the interaction between proapoptotic truncated BID (tBID) protein and mitochondrial carrier homologue 2 (MTCH2) protein: key players in mitochondrial death pathway. The Journal of biological chemistry 287, 15016-15023
  157. Galluzzi, L. et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell death and differentiation 19, 107-120
  158. Chae, H.J. et al. (2000) Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. Pharmacological research 42, 373-381
  159. Wolter, K.G. et al. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. The Journal of cell biology 139, 1281-1292
  160. Zaltsman, Y. et al. (2010) MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nature cell biology 12, 553- 562
  161. Jakobson, M. et al. (2013) Multiple mechanisms repress N-Bak mRNA translation in the healthy and apoptotic neurons. Cell death & disease 4, e777
  162. Barho, M.T. et al. (2014) N-acyl derivatives of 4-phenoxyaniline as neuroprotective agents. ChemMedChem 9, 2260-2273
  163. Fayaz, S.M. et al. (2014) Necroptosis: who knew there were so many interesting ways to die? CNS & neurological disorders drug targets 13, 42-51
  164. Martin, L.J. et al. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain research bulletin 46, 281-309
  165. Gorman, A.M. (2008) Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. Journal of cellular and molecular medicine 12, 2263-2280
  166. Uo, T. et al. (2005) Neurons exclusively express N-Bak, a BH3 domain-only Bak isoform that promotes neuronal apoptosis. J. Biol. Chem. 280, 9065-9073
  167. Yang, X. et al. (2016) Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases. Current topics in medicinal chemistry 16, 858-866
  168. Portera-Cailliau, C. et al. (1997) Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. The Journal of comparative neurology 378, 88- 104
  169. Oppermann, S. et al. (2014) Novel N-phenyl-substituted thiazolidinediones protect neural cells against glutamate-and tBid- induced toxicity. The Journal of pharmacology and experimental therapeutics 350, 273-289
  170. Ishino, Y. et al. (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of bacteriology 169, 5429-5433
  171. Zilka, O. et al. (2017) On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death. ACS central science 3, 232-243
  172. Tan, S. et al. (1998) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. Journal of neurochemistry 71, 95-105
  173. Kagan, V.E. et al. (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nature chemical biology 13, 81-90
  174. Tan, S. et al. (2001) Oxytosis: A novel form of programmed cell death. Current topics in medicinal chemistry 1, 497-506
  175. Yang, W.S. et al. (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proceedings of the National Academy of Sciences of the United States of America
  176. Dixon, S.J. et al. (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3, e02523
  177. Kelso, G.F. et al. (2002) Prevention of mitochondrial oxidative damage using targeted antioxidants. Annals of the New York Academy of Sciences 959, 263-274
  178. Kamer, I. et al. (2005) Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122, 593-603
  179. van Leyen, K. et al. (2005) Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. Journal of neurochemistry 92, 824-830
  180. Davis, J.B. and Maher, P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain research 652, 169-173
  181. Colurso, G.J. et al. (2003) Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease. Life sciences 73, 1795-1803
  182. Yagoda, N. et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864-868
  183. O'Malley, Y. et al. (2006) Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. The Journal of biological chemistry 281, 39766-39775
  184. Conrad, M. et al. (2016) Regulated necrosis: disease relevance and therapeutic opportunities. Nature reviews. Drug discovery 15, 348-366
  185. Vanden Berghe, T. et al. (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nature reviews. Molecular cell biology 15, 135-147
  186. Yang, W.S. et al. (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317-331
  187. Giménez-Cassina, A. and Danial, N.N. (2015) Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins. Trends in endocrinology and metabolism: TEM 26, 165-175
  188. Parks, T.D. et al. (1994) Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase. Analytical biochemistry 216, 413-417
  189. Mali, P. et al. (2013) RNA-guided human genome engineering via Cas9. Science (New York, N.Y.) 339, 823-826
  190. Tsujimoto, Y. (1998) Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes to cells : devoted to molecular & cellular mechanisms 3, 697-707
  191. Kelso, G.F. et al. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. The Journal of biological chemistry 276, 4588-4596
  192. Du, C. et al. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42
  193. Chou, J.J. et al. (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615-624
  194. McDonnell, J.M. et al. (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625-634
  195. Becattini, B. et al. (2006) Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proceedings of the National Academy of Sciences of the United States of America 103, 12602-12606
  196. Yang, W.S. and Stockwell, B.R. (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chemistry & biology 15, 234-245
  197. Joung, J.K. and Sander, J.D. (2013) TALENs: A widely applicable technology for targeted genome editing. Nature reviews. Molecular cell biology 14, 49-55
  198. Kazhdan, I. et al. (2006) Targeted gene therapy for breast cancer with truncated Bid. Cancer gene therapy 13, 141-149
  199. Becattini, B. et al. (2004) Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. Chemistry & biology 11, 1107-1117
  200. Oppermann, S. (2014) Targeting Bid for mitoprotection: Bid crystallization, new mechanisms and inhibitory compounds
  201. Abeti, R. et al. (2015) Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia. Pharmacological research 99, 344-350
  202. Wei, M.C. et al. (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes & development 14, 2060-2071
  203. Gonzalvez, F. et al. (2005) tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell death and differentiation 12, 614-626
  204. Shamas-Din, A. et al. (2013) tBid undergoes multiple conformational changes at the membrane required for Bax activation. The Journal of biological chemistry 288, 22111-22127
  205. Joshi, Y.B. et al. (2015) The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. Trends in pharmacological sciences 36, 181-186
  206. Rao, V.A. et al. (2010) The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. The Journal of biological chemistry 285, 34447-34459
  207. König, H.-G. et al. (2014) The BCL-2 family protein Bid is critical for pro-inflammatory signaling in astrocytes. Neurobiology of disease 70, 99-107
  208. Youle, R.J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews. Molecular cell biology 9, 47-59
  209. Hengartner, M.O. (2000) The biochemistry of apoptosis. Nature 407, 770-776
  210. Zhu, Z.-G. et al. (2017) The efficacy and safety of coenzyme Q10 in Parkinson's disease: A meta-analysis of randomized controlled trials. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 38, 215-224
  211. Bertram, L. and Tanzi, R.E. (2005) The genetic epidemiology of neurodegenerative disease. The Journal of clinical investigation 115, 1449-1457
  212. Qu, J. et al. (2016) The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria. Oxidative medicine and cellular longevity 2016, 2592935
  213. Bernardi, P. and Di Lisa, F. (2015) The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection. Journal of molecular and cellular cardiology 78, 100-106
  214. Gane, E.J. et al. (2010) The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver 30, 1019-1026
  215. Häcker, G. (2000) The morphology of apoptosis. Cell and tissue research 301, 5-17
  216. Sheng, X. et al. (2017) Theoretical insights into the mechanism of ferroptosis suppression via inactivation of a lipid peroxide radical by liproxstatin-1. Physical chemistry chemical physics : PCCP 19, 13153-13159
  217. Henke, N. et al. (2013) The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell death & disease 4, e470
  218. Shah, R. et al. (2017) The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death. ACS chemical biology
  219. Pokrzywinski, K.L. et al. (2016) Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity. PloS one 11, e0168283
  220. Tan, S. et al. (1998) The regulation of reactive oxygen species production during programmed cell death. The Journal of cell biology 141, 1423-1432
  221. Surmeier, D.J. et al. (2011) The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience 198, 221-231
  222. Esposti, M.D. (2002) The roles of Bid. Apoptosis : an international journal on programmed cell death 7, 433-440
  223. García-Sáez, A.J. (2012) The secrets of the Bcl-2 family. Cell death and differentiation 19, 1733-1740
  224. Saelens, X. et al. (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23, 2861-2874
  225. Bannai, S. and Kitamura, E. (1980) Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. The Journal of biological chemistry 255, 2372-2376
  226. Bermpohl, D. et al. (2006) Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 26, 625-633
  227. Schaefer, K.A. et al. (2017) Unexpected mutations after CRISPR-Cas9 editing in vivo. Nature methods 14, 547-548
  228. Vogt, C. (1842) Untersuchungen über die Entwicklungsgeschichte der Geburtshelferkröte (Alytes obstetricans). Jent und Gassman, Solothurn, 281-284
  229. Kvansakul, M. et al. (2008) Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell death and differentiation 15, 1564-1571
  230. Wenzel, S.E. et al. (2017) PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell 171, 628-641.e26
  231. Muchmore, S.W. et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341
  232. Gaj, T. et al. (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in biotechnology 31, 397- 405

* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten
© UB Marburg 1997 - 2024 Universitätsbibliothek Marburg